SCHEMBL10089585

SCHEMBL10089585

CCC(C)Cc1nc(SC)ncc1-c1ccnc(Nc2ccncc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 12/20 0.49
PIK3CD O00329 9/20 0.49
PIK3CA P42336 3/20 0.49
PIK3CG P48736 3/20 0.49
PI4KB Q9UBF8 2/20 0.48
CDK2 P24941 3/20 0.42
CDK4 P11802 2/20 0.42
GSK3B P49841 2/20 0.42
CAMK2D Q13557 1/20 0.37
CCNK O75909 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
CDK9 P50750 1/20 0.36
CDK19 Q9BWU1 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
TGFBR1 P36897 1/20 0.36
TGFBR2 P37173 1/20 0.36
ACVR1 Q04771 1/20 0.35
CCNA2 P20248 1/20 0.35
PIP5K1C O60331 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9957504 0.81 PIK3C3 (0.74) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL9957490 0.75 KDM4E (0.51) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL10089589 0.71 PIK3C3 (0.55) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL9957233 0.70 CDK2 (0.50) CDK2CDK4GSK3BCCNKCCNC
SCHEMBL9956682 0.68 PIK3C3 (0.79) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL9957829 0.67 PIK3C3 (0.73) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL15765721 0.67 PIK3C3 (0.73) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL16390643 0.67 PIK3C3 (0.80) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL16390620 0.67 PIK3C3 (0.76) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL16390921 0.66 PIK3C3 (1.00) PIK3C3PIK3CDPIK3CAPIK3CGPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085815-A1 BI-HETEROARYL COMPOUNDS AS VPS34 INHIBITORS NOVARTIS AG (CH) 2012-06-28 WO disclosed